Tenax Therapeutics
(TENX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 3,671 | 3,909 | 3,341 | 2,117 | 1,236 |
| Operating Income | -3,671 | -3,909 | -3,341 | -2,117 | -1,236 |
| Interest Expense | 9 | 8 | 2 | 5 | 9 |
| Other Income | 105 | 118 | 117 | 151 | 139 |
| Pre-tax Income | -3,575 | -3,799 | -3,226 | -1,972 | -1,106 |
| Net Income Continuous | -3,575 | -3,799 | -3,226 | -1,972 | -1,106 |
| Net Income | $-3,575 | $-3,799 | $-3,226 | $-1,972 | $-1,106 |
| EPS Basic Total Ops | -1.83 | -3.12 | -8.33 | -6.61 | -4.00 |
| EPS Basic Continuous Ops | -1.83 | -3.12 | -8.35 | -6.61 | -4.01 |
| EPS Diluted Total Ops | -1.83 | -3.12 | -8.33 | -6.61 | -4.00 |
| EPS Diluted Continuous Ops | -1.83 | -3.12 | -8.35 | -6.61 | -4.01 |
| EPS Diluted Before Non-Recurring Items | -1.83 | -3.12 | N/A | N/A | N/A |
| EBITDA(a) | $-3,671 | $-3,909 | $-3,336 | $-2,116 | $-1,235 |